Odaia nabs $25m in Threshold and Monograph-led Series B round

Odaia is a Toronto-based provider of automated commercial predictive insights to pharmaceutical companies.

1 May 2023•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Canada North America Deals & Exits Briefs